Astellas Pharma Inc.
Time frame: 1 February 2023 - 31 January 2024Article ‘Count’ and ‘Share’ for Astellas Pharma Inc. based on listed parameters only.
The articles listed below published by authors from Astellas Pharma Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
American Journal of Human Genetics |
1 | 0.63 |
European Urology |
2 | 0.24 |
Journal of Biological Chemistry |
1 | 0.00 |
Journal of Clinical Endocrinology & Metabolism |
1 | 0.33 |
Journal of Clinical Investigation |
1 | 0.10 |
Journal of Clinical Oncology |
3 | 0.42 |
Journal of the American Chemical Society |
1 | 0.33 |
Nature Communications |
1 | 0.16 |
Nature Medicine |
2 | 0.28 |
The Lancet |
3 | 0.91 |
The Lancet Neurology |
1 | 0.32 |
The New England Journal of Medicine |
1 | 0.10 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.